|
|
Article: PerkinElmer and Bionomics, an Australian central nervous system (CNS) and cancer biotech company, will collaborate in the evaluation and optimization of new ion channel reagents and ion channel technologies.(Organizational changes: sales/orders of note)(PerkinElmer)(Brief Article)
- Article from:
- Instrument Business Outlook
- Article date:
- June 30, 2004
CopyrightCOPYRIGHT 2004 Strategic Directions International Inc. (SDI). This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PerkinElmer and Bionomics, an Australian central nervous system (CNS) and cancer biotech company, will collaborate in the evaluation and optimization of new ion channel reagents and ion channel technologies. Bionomics will use PerkinElmer's ImageTrak kinetic cellular ...
Related newspaper, magazine, and journal articles:
|
|
Article: PerkinElmer and Axxam to Deliver Advanced Screening ...
Business Wire;
May 22, 2007 ;
700+ words
... ... program between PerkinElmer and Axxam to develop ... R]) GPCR and ion channel cell lines for ... technologies allows PerkinElmer to provide its ... positives in GPCR and ion channel screening applications. PerkinElmer estimates that ...
|
|